{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:56:08Z","timestamp":1783770968856,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Innovation Project of Guangxi Graduate Education","award":["YCSW2020120"],"award-info":[{"award-number":["YCSW2020120"]}]},{"DOI":"10.13039\/501100001809","name":"the National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81972306"],"award-info":[{"award-number":["81972306"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15474-y","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T15:33:20Z","timestamp":1756222400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lysyl oxidase as a potential biomarker of lung recurrence after hepatectomy in hepatocellular carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Wan-Ting","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Xuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Nan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"15474_CR1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ccr.2011.11.021","volume":"20","author":"RF Schwabe","year":"2011","unstructured":"Schwabe, R. F. & Wang, T. C. Targeting liver cancer: First steps toward a miracle? Cancer Cell. 20, 698\u2013699 (2011).","journal-title":"Cancer Cell."},{"key":"15474_CR2","doi-asserted-by":"crossref","unstructured":"Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87\u2013108 (2015).","DOI":"10.3322\/caac.21262"},{"key":"15474_CR3","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrgastro.2010.100","volume":"7","author":"JD Yang","year":"2010","unstructured":"Yang, J. D. & Roberts, L. R. Hepatocellular carcinoma: A global view. Nat. Rev. Gastroenterol. Hepatol. 7, 448\u2013458 (2010).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"15474_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.resinv.2015.02.004","volume":"53","author":"NA Negewo","year":"2015","unstructured":"Negewo, N. A., McDonald, V. M. & Gibson, P. G. Comorbidity in chronic obstructive pulmonary disease. Respir. Investig. 53, 249\u2013258 (2015).","journal-title":"Respir Investig"},{"key":"15474_CR5","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.7150\/jca.19056","volume":"8","author":"W Wu","year":"2017","unstructured":"Wu, W. et al. Pattern of distant extrahepatic metastases in primary liver cancer: A seer based study. J. Cancer 8, 2312\u20132318 (2017).","journal-title":"J. Cancer"},{"key":"15474_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10120-015-0510-3","volume":"19","author":"H Kasashima","year":"2016","unstructured":"Kasashima, H. et al. Lysyl oxidase is associated with the epithelial-mesenchymal transition of gastric cancer cells in hypoxia. Gastric Cancer 19, 431\u2013442 (2016).","journal-title":"Gastric Cancer"},{"key":"15474_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrc2622","volume":"9","author":"DX Nguyen","year":"2009","unstructured":"Nguyen, D. X., Bos, P. D. & Massague, J. Metastasis: From dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274\u2013284 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"15474_CR8","unstructured":"Zhou, J. et al. Guidelines for diagnosis and treatment of primary liver cancer in China (2017  Edition) Liver Cancer 7, 235\u2013260 (2018)."},{"key":"15474_CR9","doi-asserted-by":"crossref","unstructured":"Qi, L. N. et al. Circulating tumor cells undergoing emt provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma. Cancer Res. 78, 4731\u20134744 (2018).","DOI":"10.1158\/0008-5472.CAN-17-2459"},{"key":"15474_CR10","first-page":"1379","volume":"92","author":"JL Liu","year":"2012","unstructured":"Liu, J. L. et al. Mechanism of Lysyl oxidase (Lox) in breast cancer invasion and metastasis. Zhonghua Yi Xue Za Zhi 92, 1379\u20131383 (2012).","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"15474_CR11","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.7150\/jca.18466","volume":"8","author":"ZH Zhou","year":"2017","unstructured":"Zhou, Z. H. et al. Reorganized collagen in the tumor microenvironment of gastric cancer and its association with prognosis. J. Cancer 8, 1466\u20131476 (2017).","journal-title":"J. Cancer"},{"key":"15474_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/jnci\/djq569","volume":"103","author":"AM Baker","year":"2011","unstructured":"Baker, A. M. et al. The role of Lysyl oxidase in Src-dependent proliferation and metastasis of colorectal cancer. J. Natl. Cancer Inst. 103, 407\u2013424 (2011).","journal-title":"J. Natl. Cancer Inst."},{"key":"15474_CR13","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/cam4.1096","volume":"6","author":"XH Zhan","year":"2017","unstructured":"Zhan, X. H. et al. A three-gene signature from protein-protein interaction network of Loxl2- and actin-related proteins for esophageal squamous cell carcinoma prognosis. Cancer Med. 6, 1707\u20131719 (2017).","journal-title":"Cancer Med."},{"key":"15474_CR14","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1111\/cas.14010","volume":"110","author":"N Umezaki","year":"2019","unstructured":"Umezaki, N. et al. Lysyl oxidase induces epithelial-mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma. Cancer Sci. 110, 2033\u20132043 (2019).","journal-title":"Cancer Sci."},{"key":"15474_CR15","first-page":"1398","volume":"54","author":"M Yang","year":"2019","unstructured":"Yang, M. et al. Lysyl oxidase assists tumor\u2013initiating cells to enhance angiogenesis in hepatocellular carcinoma. Int. J. Oncol. 54, 1398\u20131408 (2019).","journal-title":"Int. J. Oncol."},{"key":"15474_CR16","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1007\/s10620-015-3734-5","volume":"60","author":"J Zhu","year":"2015","unstructured":"Zhu, J. et al. Lysyl oxidase is predictive of unfavorable outcomes and essential for regulation of vascular endothelial growth factor in hepatocellular carcinoma. Dig. Dis. Sci. 60, 3019\u20133031 (2015).","journal-title":"Dig. Dis. Sci."},{"key":"15474_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41389-018-0052-8","volume":"7","author":"AP Tse","year":"2018","unstructured":"Tse, A. P. et al. Hepatitis transactivator protein X promotes extracellular matrix modification through hif\/lox pathway in liver cancer. Oncogenesis 7, 44 (2018).","journal-title":"Oncogenesis"},{"key":"15474_CR18","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fonc.2015.00224","volume":"5","author":"FA Venning","year":"2015","unstructured":"Venning, F. A., Wullkopf, L. & Erler, J. T. Targeting Ecm disrupts cancer progression. Front. Oncol. 5, 224 (2015).","journal-title":"Front. Oncol."},{"key":"15474_CR19","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3892\/or.2014.3044","volume":"31","author":"Y Zheng","year":"2014","unstructured":"Zheng, Y. et al. Expression of the lysyl oxidase propeptide in hepatocellular carcinoma and its clinical relevance. Oncol. Rep. 31, 1669\u20131676 (2014).","journal-title":"Oncol. Rep."},{"key":"15474_CR20","first-page":"831","volume":"2","author":"GH Lee","year":"2011","unstructured":"Lee, G. H. et al. Lysyl oxidase-Like-1 enhances lung metastasis when lactate accumulation and monocarboxylate transporter expression are involved. Oncol. Lett. 2, 831\u2013838 (2011).","journal-title":"Oncol. Lett."},{"key":"15474_CR21","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1200\/JCO.2008.20.6003","volume":"27","author":"QT Le","year":"2009","unstructured":"Le, Q. T. et al. Validation of Lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation therapy oncology group trial 90-03. J. Clin. Oncol. 27, 4281\u20134286 (2009).","journal-title":"J. Clin. Oncol."},{"key":"15474_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/hepr.12001","volume":"43","author":"M Sakon","year":"2013","unstructured":"Sakon, M., Ogawa, H., Fujita, M. & Nagano, H. Hepatic resection for hepatocellular carcinoma based on tumor hemodynamics. Hepatol. Res. 43, 155\u2013164 (2013).","journal-title":"Hepatol. Res."},{"key":"15474_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1001\/archsurg.137.1.94","volume":"137","author":"M Sakon","year":"2002","unstructured":"Sakon, M. et al. Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: Analysis based on tumor hemodynamics. Arch. Surg. 137, 94\u201399 (2002).","journal-title":"Arch. Surg."},{"key":"15474_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/07853890.2019.1709655","volume":"52","author":"LN Qi","year":"2020","unstructured":"Qi, L. N. et al. Outcomes of anatomical versus non-anatomical resection for hepatocellular carcinoma according to circulating tumour-cell status. Ann. Med. 52, 21\u201331 (2020).","journal-title":"Ann. Med."},{"key":"15474_CR25","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1165\/rcmb.2013-0147OC","volume":"49","author":"T Mammoto","year":"2013","unstructured":"Mammoto, T., Jiang, E., Jiang, A. & Mammoto, A. Extracellular matrix structure and tissue stiffness control postnatal lung development through the lipoprotein receptor-related protein 5\/Tie2 signaling system. Am. J. Respir. Cell. Mol. Biol. 49, 1009\u20131018 (2013).","journal-title":"Am. J. Respir Cell. Mol. Biol."},{"key":"15474_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrclinonc.2011.30","volume":"8","author":"AX Zhu","year":"2011","unstructured":"Zhu, A. X., Duda, D. G., Sahani, D. V. & Jain, R. K. Hcc and angiogenesis: Possible targets and future directions. Nat. Rev. Clin. Oncol. 8, 292\u2013301 (2011).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"15474_CR27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12291-016-0576-7","volume":"32","author":"S Kumari","year":"2017","unstructured":"Kumari, S., Panda, T. K. & Pradhan, T. Lysyl oxidase: Its diversity in health and diseases. Indian J. Clin. Biochem. 32, 134\u2013141 (2017).","journal-title":"Indian J. Clin. Biochem."},{"key":"15474_CR28","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.3748\/wjg.15.5481","volume":"15","author":"KM Chan","year":"2009","unstructured":"Chan, K. M. et al. Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma. World J. Gastroenterol. 15, 5481\u20135488 (2009).","journal-title":"World J. Gastroenterol."},{"key":"15474_CR29","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1245\/s10434-010-1076-2","volume":"17","author":"A Taketomi","year":"2010","unstructured":"Taketomi, A. et al. Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann. Surg. Oncol. 17, 2740\u20132746 (2010).","journal-title":"Ann. Surg. Oncol."},{"key":"15474_CR30","doi-asserted-by":"publisher","first-page":"22773193","DOI":"10.1177\/17588359251328457","volume":"17","author":"Y Chen","year":"2025","unstructured":"Chen, Y. et al. Neoadjuvant chemotherapy combined with bevacizumab for resectable colorectal liver metastasis with risk factors for recurrence: A multicenter real-world study. Ther. Adv. Med. Oncol. 17, 22773193 (2025).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"15474_CR31","doi-asserted-by":"publisher","first-page":"e13785","DOI":"10.1002\/jcsm.13785","volume":"16","author":"Y Chen","year":"2025","unstructured":"Chen, Y. et al. Low visceral adipose tissue predicts the outcome of neoadjuvant chemotherapy for colorectal liver metastases: A multicentre real-world study. J. Cachexia Sarcopenia Muscle 16, e13785 (2025).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"15474_CR32","doi-asserted-by":"publisher","first-page":"2423043","DOI":"10.1080\/19490976.2024.2423043","volume":"16","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Kras mutations promote the intratumoral colonization of enterotoxigenic bacteroides fragilis in colorectal cancer through the regulation of the Mirna3655\/Surf6\/Irf7\/Ifnbeta axis. Gut Microbes 16, 2423043 (2024).","journal-title":"Gut Microbes"},{"key":"15474_CR33","doi-asserted-by":"publisher","first-page":"109334","DOI":"10.1016\/j.surg.2025.109334","volume":"182","author":"T Zheng","year":"2025","unstructured":"Zheng, T. et al. C-reactive protein-to-albumin ratio predicts outcome of neoadjuvant chemotherapy for colorectal liver metastases: A multicenter prediction model. Surgery 182, 109334 (2025).","journal-title":"Surgery"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15474-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15474-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15474-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T03:24:01Z","timestamp":1757474641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15474-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15474"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15474-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Ethics Committee of the Affiliated Cancer Hospital of Guangxi Medical University has approved the study protocol (Grant No.: LW2020077), and all 128 HCC patients signed the relevant informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"31465"}}